FORTE Study Updates: September 2024

September 12 2024

FORTE enrolled its 1800th participant on August 1, 2024, less than a month after enrolling the 1700th participant!  

FORTE Coordinator Session – August 7  

The FORTE Coordinator Session was held online on August 7, where presenters from various enrolling sites discussed best practices for FORTE. The recording of the session is available on the FORTE YouTube channel for your review at any time.  

Topic  

Speaker  

Introductions

Robert Schoen (FORTE Protocol Chair)  

IT Initiative, Mobile Phlebotomy, Follow-Up

Robert Schoen (FORTE Protocol Chair)  

Onboarding New Research Staff – Data Entry, Patient Contact

Kaiser Permanente Northern California (Laura Amsden)  

Communication with Patients

MetroMinn (Jodi Geer)  

Q&A Panel

ALL  

Follow-Ups

FORTE Data Manager (Izabela Frak)  

Zablocki VA (Jennifer Meulemans)  

Data Quality Management 

Zablocki VA (Amber Bishop)  

FORTE Resource Portal

FORTE Education and Communication Specialist (Cheryl Leow)  

Q&A Panel

ALL  

Survey – FORTE Coordinator Talking Points  

We need your help! During the FORTE Coordinator Session, you asked if we could update the Coordinator Talking Points document created to support research professionals as you introduce NRG-CC005 to patients. Complete this survey with your experiences talking to patients about FORTE help us update the Coordinator Talking Points. Email forte@nrgoncology.org with any additional comments you have that will help fellow coordinators enroll patients to NRG-CC005.  

Accrual Updates and Milestones (as of August 31, 2024)  

Top accruing sites: 

Kaiser Permanente – Vallejo – 1031 accrued  

UPMC-Presbyterian Hospital – 241 accrued 

Regions Hospital – 93 accrued  

Most recent randomizations:  

Kaiser Permanente-Vallejo – August 30, 2024  

Yale University – August 30, 2024 

Park Nicollet Clinic - Saint Louis Park – August 29, 2024  

UPMC-Presbyterian Hospital – August 29, 2024 

Ralph H Johnson VA Medical Center – August 29, 2024 

Recent Trial-Wide Monthly Accrual:  

June 2024 – 101 participants  

July 2024 – 104 participants  

August 2024 – 118 participants  

Find both CIRB-approved and protocol-related documents on CTSU under NRG-CC005.  

FORTE Resource Portal  

Bookmark this website, that organizes materials found on CTSU: https://www.nrgoncology.org/Clinical-Trials/NRG-CC005/FORTE-Resource-Portal. You will use the same login information as for CTSU to access this page. Once you gain access, the “FORTE Materials for Research Professionals” section contains many materials to assist you with accruing participants. This website also has contact information for questions you may have while working on NRG-CC005. 

Do you have new research team members working on NRG-CC005?  

Clinical research professionals can sign up for NRG Weekly Broadcasts to receive FORTE Fridays updates directly to your inbox: https://www.nrgoncology.org/Home/News/Weekly-Broadcasts.  

Questions from Site Research Staff

If research staff have questions about a patient's eligibility or study logistics for the NRG-CC005/FORTE Study, contact the Clinical Coordinating Department (CCD) at:FORTE@nrgoncology.orgor 1-800-477-7227.

Stay current with science. Sign up for our newsletter.

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.